Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient can take the second dose approximately 13 months after the first dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 98-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in March 2024). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient can take the second dose approximately 13 months after the first dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 11-MAR-2025 Registered nurse wanted to know if a 98-year-old patient can take the second dose approximately 13 months after the first dose or if she had to restart the administration scheme. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.